Lionco Pharmaceutical Group Co Ltd Class A 603669
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 4.89
- Day Range
- CNY 4.76–4.97
- 52-Week Range
- CNY 2.94–6.07
- Bid/Ask
- CNY 4.89 / CNY 4.90
- Market Cap
- CNY 3.53 Bil
- Volume/Avg
- 6.1 Mil / 7.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 17.82
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Lionco Pharmaceutical Group Co Ltd is engaged in the research and development of medicines. The product portfolio includes - Alanyl glutamine for injection, fructose for injection, inverted sugar for injection, xylitol for injection, riboflavin sodium phosphate for injection, and water-soluble vitamin for injection.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 497
- Website
- http://www.lingkang.com.cn
Comparables
Valuation
|
Metric
|
603669
|
600518
|
300239
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 33.72 |
Price/Book Value | 3.86 | 3.81 | 1.97 |
Price/Sales | 17.82 | 4.16 | 3.66 |
Price/Cash Flow | — | — | 16.48 |
Price/Earnings
603669
600518
300239
Financial Strength
|
Metric
|
603669
|
600518
|
300239
|
|---|---|---|---|
Quick Ratio | 2.96 | 0.80 | 3.59 |
Current Ratio | 3.24 | 1.48 | 4.57 |
Interest Coverage | −81.23 | 3.31 | 24.27 |
Quick Ratio
603669
600518
300239
Profitability
|
Metric
|
603669
|
600518
|
300239
|
|---|---|---|---|
Return on Assets (Normalized) | −13.38% | −4.99% | 4.57% |
Return on Equity (Normalized) | −21.96% | −10.43% | 6.89% |
Return on Invested Capital (Normalized) | −14.47% | −9.72% | 5.42% |
Return on Assets
603669
600518
300239
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Llgmwsfxb | Tpmc | $77.1 Bil | |
MKKGY
| Merck KGaA ADR | Cjcdxmxgg | Dqtnkb | $74.3 Bil | |
HLN
| Haleon PLC ADR | Sjdpjywz | Zdl | $37.6 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Pqzccqj | Phfc | $18.3 Bil | |
VTRS
| Viatris Inc | Jlpcbhc | Trr | $13.5 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Pbrgnhmp | Nlt | $11.7 Bil | |
CTLT
| Catalent Inc | Xyfylmhlz | Tpxgd | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Wbmcvhjd | Pdcwv | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Vvsqsqv | Svpc | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Ggrszmbkj | Sbfzznt | $3.5 Bil |